Physician profile
Bobbie Head
NPI 1053412403
$264.81
in general payments reported to CMS, 2019-2025
11 companies · $29.61 in 2025
The $29.61 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.64 · 2020: $24.95 · 2021: $66.28 · 2022: $13.93 · 2023: $53.27 · 2024: $35.13 · 2025: $29.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.01 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.01 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $130.39 | 2019-2023 | |
| Medtronic, INC. | $35.13 | 2024 | Osteocool Rf Ablation System |
| Abbvie INC. | $16.11 | 2025 | |
| Boston Scientific Corporation | $15.56 | 2019 | |
| Emd Serono, INC. | $15.15 | 2023 | Tepmetko |
| Acrotech Biopharma INC. | $13.93 | 2022 | |
| Tempus Ai, INC | $13.50 | 2025 | Xt Cdx |
| Celgene Corporation | $13.12 | 2023 | Reblozyl |
| Gilead Sciences, INC. | $11.92 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobbie Head listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.